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Introduction
The macrophage activation syndrome (MAS) in its sec-
ondary form is known to complicate rheumatic diseases as
systemic lupus erythematous (SLE) but rarely realizes a
form of revelation.
Objectives
The aim of our study is to report unrecognized MAS
manifestation as an initial symptom of SLE and describe





We report on four girls, aged of 13, 13, 10 and 7 years old,
initially admitted at our university hospital for prolonged
fever. Main infectious disease causes were ruled out and a
diagnosis of MAS was made according to the criteria of
HLH 2004. During the follow up, all patients presented
with SLE symptoms and fulfilled the modified ARA
criteria. Glomerular nephropathy was clinically diagnosed
in our four patients and was confirmed on biopsy, [Pt 1]:
class I, [Pt 2]: class V, [Pt 3]: class IV & V, [Pt 4]: class IV.
All of them had positive antinuclear and anti-dsDNA
antibodies associated to low complement levels. Patients
were treated by steroids pulse and DMARDs. The evolu-
tion was satisfactory with a follow up of 4-28 months.
Three of our patients underwent an immunological assess-
ment. Interestingly, 6 months after the MAS, [Pt 1] was
still presenting an increase of activated HLA-DR+ CD3
T cells (39.4%) with very low NK cells level. CD4+CD25
+CD127- Treg cells were also decreased. 1 month after
initial MAS, [Pt2] presented with activated CD8 T cells in
agreement with persisting MAS –related activation and
Tregs were reduced. NK cells were also decreased.
Perforin expression was normal. Pt 3 immunophenotyping
was in normal range after 28 months.
Conclusion
The diagnosis of MAS is challenging in the context of SLE
because many clinical and biological manifestations are
overlapping. It is even harder when it inaugurates lupus.
Therefore, it is crucial to consider both MAS and SLE
diagnosis in the contest of multi- visceral manifestations
with unexplained fever. Diagnosis rely on biological assess-
ment of MAS (hypertriglyceridemia , hyperferritinemia ,
cytolysis and pancytopenia) associated with the presence
of a hemophagocytes in bone aspiration. Early targeted
treatment is mandatory and overall prognosis is favorable.
As two unrelated patients have shared common clinical
and immunological features, some inherited factors may
bridge SLE and MAS pathogenesis. Whole exome sequen-
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